Introduction {#s1}
============

Pulmonary hypertension (PHpulmonary hypertension) is a heterogeneous group of diseases defined by a resting mean pulmonary artery pressure of at least 25 mm Hg ([@r1]). PHpulmonary hypertension may follow a rapidly progressive clinical course, with impaired exercise tolerance and dyspnea associated with right ventricular (RVright ventricular) hypertrophy, right-sided heart dilatation, and, ultimately, cardiac failure ([@r2]). Outcome prediction in PHpulmonary hypertension has been investigated extensively by using invasive hemodynamic data, serum biomarkers, exercise testing, and cardiac imaging. These markers consistently demonstrate that survival is related to functional adaptation of the right ventricle ([@r3]). RVright ventricular ejection fraction is a measure of global systolic function that can be used to predict survival in patients with PHpulmonary hypertension ([@r4]), although the complex shape and contraction pattern of the right ventricle make this an insensitive assessment method for early cardiac decompensation ([@r5]).

Patients investigated for PHpulmonary hypertension routinely undergo cardiac magnetic resonance (MR) imaging, which provides an accurate assessment of cardiac functional status; however, realizing the full predictive potential of cardiac imaging requires methods capable of selecting the most relevant and meaningful prognostic features ([@r6]). Computational image analysis coupled with machine learning could enable discovery of the complex functional adaptations that can be used to predict eventual right-sided heart failure and death. Unlocking the full potential of diagnostic imaging in this way has become feasible with advances in computational modeling of the structure and function of the heart ([@r7]--[@r9]). The purpose of the present study was to determine if patient survival and mechanisms of RVright ventricular failure in PHpulmonary hypertension could be predicted by using supervised machine learning of three-dimensional (3Dthree-dimensional) patterns of systolic cardiac motion.

Materials and Methods {#s2}
=====================

Study Population
----------------

This study was part of a continuous prospective research program into the prognosis of patients with PHpulmonary hypertension by using conventional clinical and imaging biomarkers. The program had ethics committee approval, and all patients gave written informed consent. Our computational analysis was retrospectively performed on the data for the UK Digital Heart Project *(*[*http://digital-heart.org*](http://digital-heart.org)*).* Patients referred to the National Pulmonary Hypertension Service at the Imperial College Healthcare NHS Trust for routine diagnostic assessment and cardiac imaging between May 2004 and October 2013 were included in the study, with end of follow-up in September 2014. Criteria for inclusion included a documented diagnosis of PHpulmonary hypertension by means of right-sided heart catheterization (RHCright-sided heart catheterization) with a resting mean pulmonary artery pressure of at least 25 mm Hg. Clinical classification was performed according to European guidelines ([@r1]), and patients with congenital shunts, arrhythmias that prevented cardiac gating, or more than 3 months between baseline investigations were excluded. All patients were treated with standard therapy in accordance with current guidelines and National Health Service England treatment policy ([@r10]).

RHC Procedure
-------------

RHCright-sided heart catheterization was performed by certified interventionists with a balloon-tipped, flow-directed Swan-Ganz catheter (Baxter Healthcare, Irvine, Calif) to derive cardiac output, cardiac index, mean pulmonary artery pressure, pulmonary capillary wedge pressure, and pulmonary vascular resistance. Six-minute walk distance was measured according to American Thoracic Society guidelines ([@r11]).

MR Imaging Protocol
-------------------

Cardiac MR imaging was performed at a single site with a 1.5-T Achieva unit (Philips, Best, the Netherlands), and a standard clinical protocol was followed according to published international guidelines ([@r12]). Ventricular function was assessed by using balanced steady-state free-precession cine images acquired in conventional cardiac short- and long-axis planes with typical parameters: repetition time (msec)/echo time (msec), 3.2/1.6; voxel size, 1.5 × 1.5 × 8 mm; flip angle, 60°; sensitivity encoding factor, two; bandwidth, 962 Hz per pixel; and temporal resolution, 29 msec. Reproducibility was assessed in 20 subjects undergoing repeat studies on the same day. Images were stored in an open-source database (MRIdb; Imperial College London, London, England).

Quantification of RV Function
-----------------------------

Volumetric analysis of cine images was performed by using a ViewForum (Philips), with one reader with 3 years of experience (T.J.W.D.) manually defining the RVright ventricular endocardial borders at end-diastole and end-systole by using a standard published protocol ([@r13]). Reference to the position of the pulmonary and tricuspid valves on long-axis images was made to ensure correct placement of the contours. Papillary muscles and trabeculae were included in the RVright ventricular volume.

Three-dimensional Assessment of Ventricular Physiology
------------------------------------------------------

Atlas-based approaches for segmenting the right ventricle enabled a 3Dthree-dimensional model of RVright ventricular structure and function to be constructed ([@r14]). To ensure a fair comparison, manual volumetry and computational analysis were both performed with the same standard cardiac MR images.

All image processing was performed in Matlab (MathWorks, Natick, Mass). We used the short-axis cine images for each patient with PHpulmonary hypertension and automatically aligned each set of end-diastolic and end-systolic images by minimizing the intensity differences between each section ([@r15]). The segmentation process was then initialized by a reader (T.J.W.D.) who placed six predefined anatomic landmarks on the target images (left ventricular apex, mitral annulus, and lateral wall; the RVright ventricular free wall; and the superior and inferior RVright ventricular insertion points \[[Fig E1](#SD2){ref-type="supplementary-material"} {online}\]). These landmarks were also defined on each labeled atlas. Manually annotated cardiac atlases at end-diastole and end-systole were derived from 47 patients with PHpulmonary hypertension and were included in the Digital Heart Project population data set for analysis of both shape and motion ([@r16]). Each voxel in the PHpulmonary hypertension atlases was manually labeled as either cavity or myocardium in the left and right ventricles by using freely available software (ITKsnap, National Library of Medicine Insight Segmentation and Registration Toolkit; [*http://www.itksnap.org/*](http://www.itksnap.org/)). With a multiatlas approach, the entire data set of labeled atlases was used, rather than relying on a model-based average representation ([@r17]). An approximate graph search was performed to find correspondences between small cubic regions, or patches, on the image to be segmented and the database of labeled atlases. Spectral embedding by using a multilayered graph of the images was used to capture global shape properties. Finally, we estimated anatomic patch correspondences on the basis of a joint spectral representation of the image and atlases ([@r14],[@r18]). The final segmentations were coregistered to an average template surface mesh, where vertex density was determined by curvature at each sampling point, allowing cardiac shape or function within the population to be compared in a common space (freely available at [*https://github.com/UK-Digital-Heart-Project*](https://github.com/UK-Digital-Heart-Project)).

Three-dimensional motion reconstruction was performed by using temporal sparse free-form registration to estimate cardiac motion between the two time points at end-diastole and end-systole ([Fig 1](#fig1){ref-type="fig"}) ([@r19]). For each endocardial vertex in the right ventricle (approximately 30 000 data points), we calculated the direction and magnitude of systolic excursion---that is, the maximal displacement from the initial position in end-diastole. Each vector was then resolved into three perpendicular components (longitudinal, circumferential, and radial) relative to a long axis defined between the tricuspid orifice and RVright ventricular apex. The resulting coregistered 3Dthree-dimensional data set represented the systolic motion of the endocardial surface of the right ventricle and septum in the PHpulmonary hypertension cohort. Patterns of 3Dthree-dimensional motion associated with survival were then assessed with supervised principal components analysis. Accuracy was assessed by comparing manual and semiautomated segmentations by using leave-one-out cross-validation, and repeatability was evaluated by measuring the agreement between the two studies.

![Example of computational modeling for a patient with idiopathic pulmonary arterial hypertension. *A,* Cine MR images were segmented by using prior knowledge from a set of disease-specific atlases. Here, the intensity image in the short-axis of the heart is overlaid with labels for left ventricular blood pool (red), myocardium (green), RVright ventricular blood pool (yellow), and free wall (blue). *B,* A 3Dthree-dimensional model at end-diastole (gray) and end-systole (blue, right ventricle; and red, left ventricle) was used to determine the direction and magnitude of systolic excursion at each corresponding anatomic point in the mesh by using a deformable motion model. *C,* A statistical model of RVright ventricular endocardial motion was used for feature selection to determine functional patterns associated with survival (relative weightings shown for the RVright ventricular free wall).](radiol.2016161315.fig1){#fig1}

Statistical Analysis
--------------------

Data were analyzed in R (R Foundation, Vienna, Austria) by using RStudio Server version 0.98 (Boston, Mass). Categorical variables were expressed as percentages. Continuous variables were expressed as means ± standard deviations or medians ± interquartile ranges for nonnormal variables. Baseline anthropometric data were compared by using unpaired *t* tests and Mann-Whitney *U* tests pending normality (continuous variables), as well as Fisher exact (nominal variables) and Cochran-Armitage (ordinal variables) tests. Intergroup age differences were controlled for by means of linear regression.

Standard principal components analysis is commonly used to summarize data into components that account for most of the variance in the observed data, but these components may not relate to markers of interest, such as outcome or survival. Supervised principal components analysis is a supervised learning approach that is effective for regression and classification problems by using complex input data ([@r20]).

The performance of each marker was tested as a predictor of survival in the whole data set, and significant univariate predictors (*P* \< .05) were carried forward to three nested models designed to test the incremental benefit of groups of predictors. Model 1 included the clinical, hemodynamic, and functional predictors found to be significant in univariate prediction. Model 2 additionally included markers of MR volumetry (RVright ventricular ejection fraction, indexed RVright ventricular end-systolic volume, indexed RVright ventricular end-diastolic volume, and stroke volume divided by RVright ventricular end-systolic volume). Model 3 included the predictors in both models 1 and 2, as well as 3Dthree-dimensional motion. Models were optimized in the training data and then assessed in the unseen validation data by using eightfold cross-validation ([Fig 2](#fig2){ref-type="fig"}) ([@r21]). In each fold, 224 cases provided the training data for a predictive model, which was then evaluated on the held-out set of 32 cases until every patient had been in a validation set exactly once. Supervised principal components analysis proceeded as follows: *(a)* A Cox proportional-hazards model was fit for each predictor, *(b)* feature selection was performed by selecting predictors with coefficients that exceeded an absolute threshold (established by means of cross-validation of the log-likelihood ratios), and *(c)* the first principal component of the reduced data matrix was used as a prognostic marker. The value of this principal component in unseen subjects was used to predict whether subjects would be alive or dead at censoring and to fit a Cox proportional-hazards model for subject survival from which model fit was measured.

![Flow diagram for recruitment and analysis of patients with PHpulmonary hypertension. Cardiac MR images were segmented and analyzed in 256 eligible patients. In the training phase, supervised machine learning was used to discover patterns of RVright ventricular function associated with outcome. Predictive performance of multivariable risk models was assessed by using eightfold cross-validation to demonstrate the incremental value of computational phenotyping. *CMR* = cardiovascular MR.](radiol.2016161315.fig2){#fig2}

Survival was recorded as the time between enrollment and death from any cause. Survival prediction for the Cox proportional-hazards model was assessed by using the hazard ratio, the *R*^2^ value for each model, and the area under the curve by using time-dependent receiver operating characteristic (ROCreceiver operating characteristic) analysis for 1-year survival ([@r22]). The model was bootstrapped (1000 bootstraps) to estimate performance metrics, which were then compared by means of analysis of variance with post hoc Tukey testing. Model performance was compared with the null hypothesis by means of permutation testing (1000 permutations), with a *P* value less than .05 considered to indicate a significant difference.

This study was conducted according to the Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis, or TRIPOD, guidelines.

Results {#s3}
=======

Study Population Characteristics
--------------------------------

In total, 405 consecutive patients referred for investigation to Imperial College Healthcare NHS Trust were evaluated for eligibility, and 256 subjects with confirmed PHpulmonary hypertension were enrolled. Of these, 36% (93 of 256) died, and one underwent lung transplantation during follow-up, which was a median length of 4.0 years (interquartile range, 2.0--5.7 years). In the cohort, 6% of patients (16 of 256) were unable to take the 6-minute walk distance test. Median patient age was 67 years (range, 52--75 years), and 143 patients (56%) were women (anthropometric, hemodynamic, and cardiac MR data are presented in [Table E1](#SD1){ref-type="supplementary-material"} \[online\]). Additional data were stratified according to PHpulmonary hypertension subgroup and are presented in [Tables E2](#SD1){ref-type="supplementary-material"}--[E4](#SD1){ref-type="supplementary-material"} (online).

Accuracy and Reproducibility of Segmentation and Motion Tracking
----------------------------------------------------------------

Mean Hausdorff distance ± standard deviation between corresponding semiautomated and manual segmentations of the right ventricle was 3.0 mm ± 1.2. Computational analysis showed good interstudy agreement according to the intraclass correlation coefficient in determining the longitudinal, radial, and circumferential positions of corresponding points in each orthogonal coordinate (intraclass correlation coefficients of 0.98, 0.98, and 0.91, respectively; all *P* \< .001) and for assessment of cardiac motion (intraclass correlation coefficients of 0.90, 0.81, and 0.82, respectively; all *P* \< .001). A 3Dthree-dimensional representation of the spatial errors in segmentation is given in [Figure E2](#SD3){ref-type="supplementary-material"} (online).

Survival Prediction
-------------------

Univariate Cox regression analyses indicated that age, sex, and race ("clinical markers"), mean right atrial pressure and RVright ventricular end-diastolic pressure ("hemodynamic markers"), functional class and 6-minute walk distance ("functional markers"), and all baseline cardiac MR measurements ("volumetric markers") were significantly associated with survival ([Table E1](#SD1){ref-type="supplementary-material"} \[online\]). Univariate standardized hazard ratios for each predictor and Kaplan-Meier estimates of survival used to compare RVright ventricular ejection fraction to 3Dthree-dimensional motion analysis are shown in [Figure 3](#fig3a){ref-type="fig"}.

![A comparison of survival prediction for each parameter is shown. **(a)** Standardized hazard ratios *(HRs)* (for a 1.96 standard deviation difference) with 95% confidence intervals *(CIs)* are shown for 3Dthree-dimensional motion and conventional prognostic markers. **(b)** Kaplan-Meier curves and numbers at risk for the survival of patients with PHpulmonary hypertension were used to compare risk stratification according to 3Dthree-dimensional motion versus RVright ventricular ejection fraction *(RVEF). mPAP* = mean pulmonary artery pressure, *mRAP* = mean right atrial pressure, *PVR* = pulmonary vascular resistance, *RAP* = right atrial pressure, *RVEDP* = RVright ventricular end-diastolic pressure, *RVEDVI* = indexed RVright ventricular end-diastolic volume, *RVESVI* = indexed RVright ventricular end-systolic volume, *SV/ESV* = stroke volume divided by end-systolic volume, *6MWD* = 6-minute walk distance.](radiol.2016161315.fig3a){#fig3a}

![A comparison of survival prediction for each parameter is shown. **(a)** Standardized hazard ratios *(HRs)* (for a 1.96 standard deviation difference) with 95% confidence intervals *(CIs)* are shown for 3Dthree-dimensional motion and conventional prognostic markers. **(b)** Kaplan-Meier curves and numbers at risk for the survival of patients with PHpulmonary hypertension were used to compare risk stratification according to 3Dthree-dimensional motion versus RVright ventricular ejection fraction *(RVEF). mPAP* = mean pulmonary artery pressure, *mRAP* = mean right atrial pressure, *PVR* = pulmonary vascular resistance, *RAP* = right atrial pressure, *RVEDP* = RVright ventricular end-diastolic pressure, *RVEDVI* = indexed RVright ventricular end-diastolic volume, *RVESVI* = indexed RVright ventricular end-systolic volume, *SV/ESV* = stroke volume divided by end-systolic volume, *6MWD* = 6-minute walk distance.](radiol.2016161315.fig3b){#fig3b}

Feature extraction and supervised learning from the data are shown in [Figure 4](#fig4){ref-type="fig"}. All three nested prediction models were significant when compared with the null hypothesis (all *P* \< .001), and there was a significant difference between the predictive power of the models (analysis of variance hazard ratio, *F* = 80.2 \[*P* \< .001\]; area under the ROCreceiver operating characteristic curve, *F* = 94.2 \[*P* \< .001\]; *R*^2^ analysis, *F* = 40.7 \[*P* \< .001\]). Model 3, which included 3Dthree-dimensional motion, had a significantly higher hazard ratio, area under the ROCreceiver operating characteristic curve, and *R*^2^ value, and a greater difference in median survival time (all *P* \< .001) ([Table](#tbl1){ref-type="table"}). Five-year survival from time of diagnosis according to quartiles of risk predicted with model 3 is shown in [Figure 5](#fig5){ref-type="fig"}.

![Illustration of how features of RVright ventricular motion are automatically selected for prognostic importance in patients with PHpulmonary hypertension. *A,* Plot represents how the magnitude of systolic excursion in the right ventricle, derived from atlas-based cardiac segmentations, varies between survivors and nonsurvivors from the basal level to the apical level. *B,* Plot shows where supervised machine learning identifies features within these motion-based data that most accurately allow discrimination between low-risk and high-risk patients. The full model used for survival prediction took into account the prognostic importance of motion throughout a 3Dthree-dimensional representation of the right ventricle, resolved into orthogonal components.](radiol.2016161315.fig4){#fig4}

###### 

Survival Prediction in the Validation Cases

![](radiol.2016161315.tbl1)

Note.---Numbers in parentheses are 95% confidence intervals. Clinical markers were age, sex, race, and PHpulmonary hypertension subtype; RHCright-sided heart catheterization hemodynamic markers were right atrial pressure and RVright ventricular end-diastolic pressure. Functional markers were New York Heart Association functional class and 6-minute walk distance. MR markers were RVright ventricular end-diastolic volume index, RVright ventricular end-systolic volume index, RVright ventricular ejection fraction, and stroke volume divided by RVright ventricular end-systolic volume. The 3Dthree-dimensional marker was 3Dthree-dimensional motion. Area under the ROCreceiver operating characteristic curve indicates the performance of each marker in 1-year survival prediction. In subgroups with more than 50% survival at censoring, median survival values were extrapolated. All models were significantly better predictors than the null hypothesis (*P* \< .001).

![Graph shows observed 5-year survival from the time of diagnosis according to predicted risk strata obtained by using model 3, as described in the [Table](#tbl1){ref-type="table"}.](radiol.2016161315.fig5){#fig5}

Functional Contributions to Survival and Ventricular Function
-------------------------------------------------------------

Systolic function throughout most of the right ventricle and septum was influential in patient survival ([Fig 6](#fig6){ref-type="fig"}). Reduced longitudinal excursion throughout the basal and midventricular regions was associated with poor outcome. A decrease in radial contraction in the septum and free wall also had prognostic significance. Mortality was also predicted by a global increase in circumferential function. Machine-learning analysis from the motion data sets enabled prediction of survival in all three PHpulmonary hypertension subgroups (all *P* \< .001), and the variation in cardiac function between groups is shown in [Figure E3](#SD4){ref-type="supplementary-material"} (online).

![A 3Dthree-dimensional model of the right ventricle shows the regional contributions to survival prediction in 256 patients with PHpulmonary hypertension. The models show where reduced (red) or increased (blue) systolic motion is associated with death. This is shown by, *A,* the magnitude of excursion, as well as, *B--D,* each directional component. The right ventricle is shown in the anterior and septal views, with the left ventricle depicted as a mesh. A reduction in both longitudinal basal motion and transverse bellows contraction is associated with death, as is an increase in circumferential contraction.](radiol.2016161315.fig6){#fig6}

Discussion {#s4}
==========

Semiautomated analysis of cine cardiac MR images in patients with PHpulmonary hypertension is feasible, accurate, and reproducible. Supervised machine learning of the patterns of cardiac motion indicates that survival in patients with PHpulmonary hypertension is predicted by a loss of effective contractile motion in anatomically distinct but functionally synergistic regions of the right ventricle. A machine-learning survival model that includes cardiac motion has incremental prognostic power when compared with conventional parameters.

Computational modeling provides a platform for improving our understanding of the heart, and the integration of experimental and clinical data is now bringing computational models closer to use in routine clinical practice ([@r23]). Advances in both cardiac imaging and analytic models offer a wealth of biological data that contribute to the search for novel biomarkers of cardiac dysfunction. Multimodal techniques can now offer biventricular electromechanical modeling, fluid-solid mechanical models, and luminal flow streamlines coupled with myocardial displacement ([@r24],[@r25]). Atlas-based analysis in the heart has been applied to describing shape variation among asymptomatic adults, identifying persisting effects of preterm delivery on ventricular geometry, and demonstrating patterns of remodeling after myocardial infarction ([@r9],[@r26],[@r27]). The potential for this technique lies not just in shape analysis but as a means to understand how the integrated function of the heart contributes to survival in large clinical cohorts as the data from each subject are coregistered. While other approaches to cardiac segmentation are more widely available, atlas-based methods maintain the anatomic correspondence of the 3Dthree-dimensional mesh between patients. Machine learning, both supervised and unsupervised, can be applied to clinical data sets for the purpose of developing robust risk models and redefining patient classes ([@r28]). In this study, we used a complex 3Dthree-dimensional model of cardiac displacement and applied a machine-learning algorithm to identify recurring patterns within this high-dimensional data set that enabled prediction of outcomes most strongly. From standard diagnostic imaging, a mathematical model of the relationship of cardiac function to survival can be generated.

Conventional cardiac MR studies in PHpulmonary hypertension have shown that deteriorating RVright ventricular function is associated with poor outcome, despite therapeutic reductions in pulmonary vascular resistance ([@r4]). Imaging can be used to assess RVright ventricular systolic function in several ways, typically by means of global measures of pump function or regional systolic excursion ([@r29]). Our models indicate that survival is linked to a combined failure of basal longitudinal shortening and transverse contraction of the septum and free wall. The importance of these individual components of motion to pump function has been proposed previously in physiological studies ([@r30]), and here we demonstrate the combined influence on outcome. The modeling also demonstrates the risk associated with adaptations of circumferential function, which tends to increase in PHpulmonary hypertension as global failure develops ([@r31]). Raised afterload and RVright ventricular dilatation are associated with fiber reorientation toward the circumferential direction ([@r32]), and our data indicate that such adverse structural remodeling independently contributes to survival. The predictive performance of machine learning is independent of PHpulmonary hypertension subtype, but the models identify some prognostic variations in RVright ventricular geometry and function that may reflect differing responses to altered loading conditions. These integrative models of right-sided heart physiology show that cardiac decompensation is not simply a global decline in function but instead results from a loss of effective contractile motion in anatomically distinct but functionally synergistic regions.

Innovation in biomarker discovery and personalized medicine requires a cultural change in how clinical data are exploited ([@r6]). Here we have demonstrated how it is possible to maximize the potential of existing imaging resources for outcome prediction by using computational models that require minimal human intervention. As well as performing accurate risk classification of individual patients, the models also inform clinicians about the functional mechanisms that underlie RVright ventricular failure. The potential for such computational simulations lies not only in risk stratification but also in designing trials for new therapies that have a direct effect on RVright ventricular contractility. Future work will be directed at improving the depth of phenotyping by using time-resolved segmentations throughout the cardiac cycle to model 3Dthree-dimensional strain tensors, evaluating machine-learning predictions in an independent validation cohort benchmarked against conventional multivariate risk models, and exploring the potential of deep learning architectures for hierarchical feature recognition ([@r33],[@r34]).

Our study has limitations. The pragmatic study design, which included all noncongenital cases of PHpulmonary hypertension and all treatment regimens, may limit applicability in selective groups but demonstrates that the methods are effective across a spectrum of disease and treatments. We classified our patients according to international guidelines, but it is recognized that patients with PHpulmonary hypertension have multifactorial disease with overlap between categories. Study end point and censoring were confined to all-cause mortality to avoid bias in the classification of cause of death, though the performance of markers will also be affected by variations in therapy and those selected for surgery. The accuracy of our segmentation technique compares well to that in previously published results ([@r14]); however, the uncertainty in both end-diastolic and end-systolic segmentation will propagate to the uncertainty in displacement estimation. Our models are also currently limited to measuring excursion rather than contractility, and deriving strain tensors may add additional prognostic data ([@r34]). Human intervention is limited to landmark placement, but newer techniques offer a means to also automate this step ([@r35]). We considered only the first supervised principal component of the 3Dthree-dimensional functional model, as this explains the most variance in data as is possible and allows a fair comparison with other single-parameter predictors. The cumulative variance of subsequent components may further improve prediction, although later components are increasingly influenced by noise. Contemporaneous echocardiography and cardiopulmonary exercise testing were not available for each case. Tricuspid annular-plane systolic excursion offers a prognostic indicator that is simple to measure, and although we confirm the importance of basal longitudinal excursion to survival, the models show that regional contraction in the circumferential and radial directions also contribute to prognosis.

In conclusion, applying machine learning of complex motion phenotypes obtained from cardiac MR imaging allows more accurate prediction of patient outcomes in PHpulmonary hypertension.

Advances in Knowledge
---------------------

1.  ■ A disease-specific cardiac atlas can be used to create accurate (Hausdorff distance, 3.0 mm ± 1.2) and reproducible (intraclass correlation coefficients for agreement of position in each axis, 0.98, 0.98, and 0.91; all *P* \< .001) segmentations of the heart in pulmonary hypertension (PHpulmonary hypertension) from conventional cardiac MR images.

2.  ■ A supervised machine-learning survival model that includes three-dimensional cardiac motion provides incremental prognostic benefit when compared with conventional imaging and hemodynamic, functional, and clinical markers (area under the receiver operating characteristic curve, 0.73 vs 0.60, respectively \[*P* \< .001\]; difference in median survival time between high- and low-risk groups, 13.8 vs 10.7 years, respectively \[*P* \< .001\]).

Implications for Patient Care
-----------------------------

1.  ■ Computational analysis of right ventricular motion in PHpulmonary hypertension can be used for risk stratification and demonstrates early prognostic signs of dysfunction.

2.  ■ Machine learning by using cardiac MR imaging should be evaluated as a tool to guide patient management.

APPENDIX {#s5}
========

SUPPLEMENTAL FIGURES {#s6}
====================
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